CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results – GlobeNewswire (press release)
GlobeNewswire (press release) |
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results
GlobeNewswire (press release) ZUG, Switzerland and CAMBRIDGE, Mass., March 08, 2018 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, today provided a business update … UPDATE: CRISPR Therapeutics (CRSP) PT Raised to $59 at Barclays, Street High Crispr Therapeutics (CRSP) Now Covered by JMP Securities 11.43 % to Target, Barclays Reaffirms '”Overweight”' Rating on CRISPR Therapeutics (CRSP) Shares Today |
